Trending...
- Reflectel Mirror TV + HearthCabinet® Ventless Fireplaces: Designing the Future of Luxury Interiors
- Naturally New York Announces Inaugural Holiday Bazaar Event, Presented by Bank of America
- Connecting Talent with Opportunity: TrueGigs Staffing Solutions Debuts New Platform
Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.
JUPITER, Fla. - Nyenta -- To accommodate the exploding need for neurology services in Palm Beach, Martin, and St. Lucie counties, Jupiter Neurologist, Dr. Jeff Gelblum, proudly announces the expansion of his in-office infusion center located at 601 University Boulevard, Suite 102, in Jupiter, Florida.
Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.
"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.
The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.
More on Nyenta.com
He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."
About Jeffrey Gelblum, MD, FAAN
Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.
Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.
Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.
"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.
The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.
More on Nyenta.com
- Rochester: City Launches Community-Wide Survey on the Impact of the Opioid Epidemic
- New Rochelle: December Events!
- Invenio IT Expands Cybersecurity Offerings with Datto Antivirus (AV)
- Long Island Company Offers Heated Restroom Trailers for Winter Events
- The WIT (Women in Technology) Network Appoints Cheryl Stookes as Strategic Advisor
He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."
About Jeffrey Gelblum, MD, FAAN
Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.
Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.
Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
Filed Under: Health
0 Comments
Latest on Nyenta.com
- LG CNS to Launch Smart Building DX Business in the U.S.
- Dr. Juan-Carlos Barrera-Martinez Joins Park Avenue Medicine & Surgery: Elevating Neurological Care
- Free Doctor Visits and Prescriptions in Long Island City, Queens
- South Asians on Broadway to Produce Holiday Fundraising Concert
- Rochester: Holidays at the Market Continues on Sunday
- New Rochelle Launches AI-Powered Chatbot for City Website
- ONE Gas to Participate in Jefferies, Mizuho, and Wells Fargo Utility Conferences
- Rochester: City reminds residents of support resources during holiday season
- Rosann Santos Gives Tips To Stop Distracting Your Team Members On The Two-Minute Mentor
- Mrs Elemental® USA Rebrands to Empower Married Women Across the Nation
- Visual Comfort & Co. Opens New Showroom in SoHo, New York
- Creative Biolabs—Improving Antibody Engineering Through Recombinant Approaches
- Biovenic: Driving Innovation in Animal Breeding for a Sustainable Future
- Canyon Partners Expands Product Team with Senior Hire
- Time to Investigate Mental Health Research Waste on Bizarre Animal Studies
- Shawmut Design and Construction Builds Out Large Project Division in New York Metro Region to Advance Strategic Growth
- Park Avenue Medicine & Surgery Introduces Exclusive Concierge Medicine Membership
- MTCH Investors Have Opportunity to Lead Match Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
- The World's No.1 Superstar Is Celebrating His 21st Birthday for the 28th Time Today!
- DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation